PITX2 regulates procollagen lysyl hydroxylase (PLOD) gene expression: Implications for the pathology of Rieger syndrome

Citation
Ta. Hjalt et al., PITX2 regulates procollagen lysyl hydroxylase (PLOD) gene expression: Implications for the pathology of Rieger syndrome, J CELL BIOL, 152(3), 2001, pp. 545-552
Citations number
45
Categorie Soggetti
Cell & Developmental Biology
Journal title
JOURNAL OF CELL BIOLOGY
ISSN journal
00219525 → ACNP
Volume
152
Issue
3
Year of publication
2001
Pages
545 - 552
Database
ISI
SICI code
0021-9525(20010205)152:3<545:PRPLH(>2.0.ZU;2-D
Abstract
The Rieger syndrome is an autosomal dominant disease characterized by ocula r, craniofacial, and umbilical defects. Patients have mutations in PITX2, a paired-bicoid homeobox gene, also involved in left/right polarity determin ation. In this study we have identified a family of genes for enzymes respo nsible for hydroxylizing lysines in collagens as one group of likely cognat e targets of PITX2 transcriptional regulation. The mouse procollagen lysyl hydroxylase (Plod)-2 gene was enriched for by chromatin precipitation using a PITX2/Pitx2-specific antibody. Plod-2, as well as the human PLOD-1 promo ters, contains multiple bicoid (PITX2) binding elements. We show these elem ents to bind PITX2 specifically in vitro. The PLOD-1 promoter induces the e xpression of a luciferase reporter gene in the presence of PITX2 in cotrans fection experiments. The Rieger syndrome causing PITX2 mutant T68P fails to induce PLOD-l-luciferase. Mutations and rearrangements in PLOD-1 are known to be prevalent in patients with Ehlers-Danlos syndrome, kyphoscoliosis ty pe (type VI [EDVI]). Several of the same organ systems are involved in Rieg er syndrome and EDVI.